An antibiotic used to treat infective diarrhoea could be an effective drug for a type of inflammatory bowel disease, a new study has found.

Patient activation, earned trust and health literacy at patient, provider and health system levels are critical to overcoming ...

For older adults with inflammatory bowel disease (IBD), there was no significant difference in the risk of major ...

IBD Aware, a wearable medical device in development for patients with inflammatory bowel disease, aims to improve disease ...

The Financial Select Sector SPDR Fund ETF trades in a buy zone as XLF holdings Berkshire Hathaway, Visa, Mastercard, JPMorgan ...

Hims stock surged into a profit-taking zone Friday after facing backlash over its provocative Super Bowl ad that criticized ...

Bill Holdings tried to break out ahead of earnings. The IBD 50 stock plunged 30% on earnings on Friday, triggering a sell signal.

Construction materials supplier CRH cleared a buy point Thursday after announcing plans to unload its stake in SigmaRoc.

No significant difference in the risk for MACE was observed between patients with IBD receiving JAK vs TNF inhibitors.

SAN FRANCISCO -- Janus kinase (JAK) inhibitors appeared to be a safe, effective option for treating inflammatory bowel ...

Queensland has the third highest prevalence of a debilitating bowel disease that impacts 180,000 Australians, costing ...

Researchers from The Institute of Cancer Research in London have developed a new test that can predict colorectal cancer risk ...